A shocking claim has emerged from within the FDA, raising critical questions about the safety of COVID-19 vaccines for children. In a move that’s sure to spark intense debate, Dr. Vinay Prasad, the FDA’s chief medical and scientific officer, has announced plans to overhaul the vaccine approval process, alleging that COVID-19 shots were linked to the deaths of 10 children. But here’s where it gets controversial: Prasad argues that healthy children, who faced minimal risk from the virus itself, were pressured into vaccination through school and work mandates, potentially leading to tragic outcomes. And this is the part most people miss: Prasad’s memo, obtained by CNN, doesn’t provide detailed evidence of these deaths but cites an initial analysis of 96 cases, 10 of which were purportedly tied to the vaccine. He further contends that COVID-19 was never a significant threat to children, comparing its impact to other respiratory viruses that don’t warrant annual vaccines.
Prasad isn’t dismissing vaccines outright—he acknowledges their life-saving potential but emphasizes that, like any medical product, they must be used appropriately. Here’s the kicker: He believes the FDA’s current approval process falls short, particularly for vulnerable groups like pregnant women and children. As a result, the agency plans to tighten safety and efficacy standards, requiring more robust evidence before vaccines hit the market. This could mean longer, larger studies, significantly slowing down approvals.
But here’s the real question: Is this a necessary correction or an overreaction? Prasad’s stance aligns with long-standing arguments from figures like HHS Secretary Robert F. Kennedy Jr., a vocal critic of vaccine safety who has slashed funding for mRNA research and pushed controversial changes at the CDC. Kennedy’s advisory committee, handpicked by him, is now considering delaying the hepatitis B vaccine for infants—a move that could undo decades of progress in eradicating a deadly disease.
This isn’t just a bureaucratic shake-up; it’s a fundamental reevaluation of how we approach public health. Prasad is inviting internal debate but has made it clear: those who disagree should resign. What do you think? Is this a bold step toward safer vaccines, or a dangerous shift that undermines public trust? Let’s hear your thoughts in the comments—this conversation is too important to ignore.
